Neuromyelitis Optica Spectrum Disorder Treatment Market By Treatment Type (Monoclonal Antibodies {Complement Inhibitors, CD19-Targeting Agents, IL-6 Receptor Inhibitors, Others}, Immunosuppressants {Purine Analogues, CD20-Targeting Agents, Others}, Corticosteroids {Methylprednisolone, Oral Corticosteroids}, Plasma Exchange Therapy, Others), By Patient Type (AQP4-IgG Positive Patients, AQP4-IgG Negative Patients), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-user (Hospitals & Specialty Clinics, Research Institutes & Academic Centers, Homecare Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Treatment Type

• Monoclonal Antibodies
  • Complement Inhibitors
  • CD19-Targeting Agents
  • IL-6 Receptor Inhibitors
  • Others
• Immunosuppressants
  • Purine Analogues
  • CD20-Targeting Agents
  • Others
• Corticosteroids
  • Methylprednisolone
  • Oral Corticosteroids
• Plasma Exchange Therapy
• Others

By Patient Type

• AQP4-IgG Positive Patients
• AQP4-IgG Negative Patients

By Route of Administration

• Oral
• Intravenous
• Subcutaneous

By End-user

• Hospitals & Specialty Clinics
• Research Institutes & Academic Centers
• Homecare Settings
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Roche
• AstraZeneca
• UCB Pharma
• Novartis
• Bristol Myers Squibb
• Mitsubishi Tanabe Pharma
• Sanofi
• Biogen
• Eisai
• Teva Pharmaceutical Industries
• AbbVie
• Bayer
• Merck & Co.
• Horizon Therapeutics
• Regeneron Pharmaceuticals